Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
99 100 Next >
Eli Lilly's Alzheimer's Drug, Donanemab Faces FDA's Adcomm Vote Next Week On Data, Risk Profile
Via Benzinga
Exposures Product Safety
Tickers LLY
Novavax Stock Soars On FDA COVID-19 Update: Fundamental Rally Or Potential Short Squeeze?
Via Benzinga
Exposures COVID-19 Product Safety
Tickers NVAX
FDA Committee 'Completely Lost Sight Of The Big Picture' Says Retired Lieutenant General Urging Approval On MDMA For PTSD
Via Benzinga
Exposures Product Safety
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program
Via Benzinga
Exposures Product Safety
Tickers MRNA
What's Going On With Novavax Stock Thursday?
Via Benzinga
Exposures COVID-19 Product Safety
Tickers NVAX
Readers’ Favorite announces the review of the Fiction – New Adult book “Choices” by Gary Markman
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Is A Tax On Organic Cows Or An Outright Ban Coming Soon?
Via Talk Markets
Topics Emissions
Exposures Product Safety
Novavax, With A 369% Gain, Tears Ahead Again On Key FDA Move
Via Investor's Business Daily
Exposures COVID-19 Product Safety
Tickers MRNA NVAX PFE
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
Via Benzinga
Exposures Product Safety
Tickers ATAI CYBN MNMD PSIL
Medtronic Recalls Some Versions Of Software Used For Cranial Surgery
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers MDT
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers LEXX
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study
Via CannabisNewsWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers LEXX
FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates
Via Benzinga
Exposures Product Safety
Nihar Gala Unveils Innovative Solution for Fitness Goals: Compounded Semaglutide Now Available at Alpha Care Medical
Via Get News
Exposures Product Safety
Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV
Via AB Newswire
Exposures Product Safety
Tickers AAPL INBS JAGX NVDA
Top Threat Modeling Resources for Medical Device Cybersecurity
Via Syndication Cloud
Exposures Product Safety
What's Going On With FibroGen Stock Tuesday?
Via Benzinga
Exposures Product Safety
Tickers FGEN REGN
Cucumber Recall 2024: 14 States Hit With Cucumber Recalls Over Salmonella Concerns
Via InvestorPlace
Topics Product Recall
Exposures Legal Product Safety
Tickers WIMI
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Pre-IND Submission for Proprietary Treatment for PTSD, Anxiety
Via Investor Brand Network
Exposures Product Safety
Tickers SILO
Actuated Medical Launches My Medical Mirror Companion Case and website: helping Older Adults with transitions in care
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Medicine Hat Entrepreneur Amanda Totchek Featured in Exclusive Inspirery Interview
Via Get News
Topics Product Recall
Exposures COVID-19 Legal Product Safety
Toyota's Quality Control In Question: Japanese Auto Giant Recalls 100K Cars In US Over Engine Debris Fears
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TM
Silo Pharma’s (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors
Via AB Newswire
Exposures Product Safety
Tickers SILO
FibroGen Stock Is Surging After The Bell: What's Going On?
Via Benzinga
Exposures Product Safety
Tickers FGEN REGN
MDMA Therapy For PTSD Closer To Legality As Key FDA Approval Meeting Approaches, Sparking Hope And Controversy
Via Benzinga
Exposures Product Safety
Why Microbot Medical Stock Is Up
Via Benzinga
Exposures Product Safety
Tickers MBOT
Sector Spotlight: Orphan Drug Developers With Significant Upside
Via AB Newswire
Topics ETFs
Exposures Product Safety
Tickers CRDL KNSA TSX:CRDL
Sector Spotlight: Orphan Drug Developers With Significant Upside
Via TheNewswire.com
Topics ETFs
Exposures Product Safety
Tickers CRDL KNSA TSX:CRDL
Sector Spotlight: Orphan Drug Developers With Significant Upside
Via News Direct
Topics ETFs
Exposures Product Safety
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers
Via AB Newswire
Exposures Product Safety
Tickers ABEO ADAP INBS MYMD
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.